Test Price
2,800 AED✅ Home Collection Available
COG1 Gene Glycosylation Disorder Type 2G (COG1-CDG) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COG1 لاضطراب الغلكزة النوع الثاني G (COG1-CDG) بتقنية تسلسل الجيل التالي (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان دقة بنسبة 99.9%، وتغطية تأمينية مباشرة، وجمع منزلي فاخر، وإرشاد سريري هاتفي بعد الفحص.
Test Overview
This state-of-the-art genetic test utilises targeted Next-Generation Sequencing (NGS) to detect pathogenic variants in the COG1 gene, confirming congenital disorder of glycosylation type IIg (COG1-CDG) — a rare multisystemic condition often presenting in infancy. In the UAE, timely diagnosis empowers families with precise management strategies and access to specialised multidisciplinary care under DHA-endorsed protocols.
Why Choose Our COG1-CDG NGS Test?
| Feature | Our Test | Standard Alternative |
|---|---|---|
| Methodology | NGS with ACMG-guided variant interpretation and Sanger confirmation | Single‑gene Sanger only (limited coverage) |
| Turnaround Time | 3–4 Weeks | 6–8 weeks |
| Precision | 99.9% Diagnostic Sensitivity (ISO 9001:2015) | Variable, often without external quality assurance |
| Sample Type | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | Whole Blood only |
Physician Insight & Safety Protocol
A Clinician’s Perspective from Dr. Prabhakar Reddy (DHA: 61713011)
“As a clinician, I emphasise that a genetic result is not a standalone diagnosis; it must be interpreted alongside biochemical markers and clinical findings. Families often face a long diagnostic odyssey, and this test, when ordered appropriately, can bring clarity and hope. I strongly advise involving a Clinical Geneticist or Paediatric Metabolic Specialist to guide management and counselling.”
⚠️ Important: Do not discontinue prescribed medication without consulting your doctor. Genetic results may influence treatment but never replace ongoing clinical care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not suitable as a stand‑alone screen for unrelated conditions; patients with acute life‑threatening crises require immediate medical stabilisation before specimen collection.
- Red Flag Symptoms: Rapid neurological deterioration, uncontrolled seizures, or metabolic acidosis warrant emergency department evaluation—do not wait for genetic results.
- Minors: Genetic testing of minors follows the UAE’s CDS Law 2026; prior written consent from legal guardians and a genetic counselling session are mandatory.
Patient FAQ & Clinical Guidance
1. What is the COG1-CDG NGS test and who should consider it?
This NGS test identifies mutations in the COG1 gene causing congenital disorder of glycosylation type IIg, aiding definitive diagnosis for symptomatic individuals and carrier screening for at‑risk families. Children with developmental delay, failure to thrive, liver dysfunction, or coagulation abnormalities are typical candidates. Adults with mild phenotypes or a family history of unexplained infant deaths may also benefit. The test is ordered by a Clinical Geneticist, Pediatric Metabolic Specialist, or informed primary care physician after pre‑test counselling.
يكتشف هذا الفحص بالـNGS الطفرات في جين COG1 المسببة لمرض اضطراب الغلكزة النوع الثاني G، مما يساعد في التشخيص النهائي وفحص الحاملين للعائلات المعرضة للخطر. يُنصح به للأطفال الذين يعانون من تأخر النمو أو خلل الكبد أو التخثر، وللبالغين الذين لديهم تاريخ عائلي مشتبه.
2. How is the sample collected and is home collection available?
A simple blood draw or dried blood spot card is collected, with VIP mobile phlebotomy and cold‑chain transport available across all UAE emirates. Our team follows ISO 9001:2015 protocols to maintain sample integrity from your doorstep to the laboratory. You can schedule a home visit between 8 AM and 11 PM, seven days a week. Dry blood spot samples are ideal for infants or when venous access is challenging, and they remain stable at room temperature for short periods.
يتم جمع عينة دم بسيطة أو بقعة دم على بطاقة FTA، مع خدمة الفصد المنزلي الفاخر والنقل المبرد المعتمد في جميع الإمارات. تتوفر الزيارات المنزلية يومياً من الساعة 8 صباحاً حتى 11 مساءً.
3. What do the results mean and what support is provided?
A positive result confirms a diagnosis of COG1-CDG and opens access to targeted therapies, while a variant of uncertain significance requires expert correlation. All reports are reviewed by a board‑certified molecular geneticist and include a clinical interpretation. We offer post‑ telephonic guidance in English and Arabic to explain the findings and recommend further steps, such as referral to a metabolic specialist or family screening. Your data is protected under UAE PDPL, and results are shared only with your referring physician.
النتيجة الإيجابية تؤكد تشخيص COG1-CDG وتُتيح الوصول لعلاجات متخصصة؛ أما المتغيرات غير المؤكدة فتتطلب تقييماً خبيراً. نقدم إرشاداً هاتفياً بعد الفحص بالعربية والإنجليزية، مع حماية كاملة للبيانات بموجب قانون حماية البيانات الشخصية الإماراتي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians